Tenaya Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	45.68	95.27	38.13	128.54	23.87
Short-Term Investments	58.96	91.26	213.17	0	2.75
Cash & Cash Equivalents	104.64	186.53	251.3	128.54	26.63
Cash Growth	-43.90%	-25.78%	95.51%	382.76%	-
Other Current Assets	6.94	7.23	4.06	1.43	1.12
Total Current Assets	111.58	193.75	255.36	129.96	27.74
Property, Plant & Equipment	53.26	62.7	54.71	17.19	9.58
Long-Term Investments	0	17.7	0	0.55	0.4
Other Long-Term Assets	5.68	4.79	4.13	0.47	0.29
Total Long-Term Assets	58.93	85.19	58.83	18.2	10.26
Total Assets	170.52	278.95	314.19	148.16	38
Accounts Payable	5.63	9.58	10.72	1.02	0.6
Current Debt	4.32	4.01	1.99	0	0
Other Current Liabilities	12.78	10.66	9.06	4.02	3.52
Total Current Liabilities	22.73	24.25	21.77	5.04	4.12
Long-Term Debt	8.11	11.09	13.71	0	0
Other Long-Term Liabilities	0.25	0.23	0.18	3.68	4.58
Total Long-Term Liabilities	8.36	11.32	13.89	3.68	4.58
Total Liabilities	31.09	35.57	35.66	8.72	8.7
Total Debt	12.42	15.1	15.7	0	0
Debt Growth	-17.72%	-3.83%	-	-	-
Retained Earnings	-403.28	-279.2	-155.53	-82.81	-44.42
Comprehensive Income	-0.11	-0.38	-0.14	0	0
Shareholders' Equity	139.42	243.38	278.53	-81.32	-43.74
Net Cash / Debt	92.22	171.43	235.6	128.54	26.63
Net Cash / Debt Growth	-46.21%	-27.24%	83.30%	382.76%	-
Net Cash Per Share	1.25	3.82	13.29	132.23	5.87
Working Capital	88.85	169.51	233.58	124.92	23.62
Book Value Per Share	1.89	5.43	15.71	-83.65	-9.64

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).